Whole-body heat with chemotherapy for advanced pancreatic cancer
Part of Injuries & trauma clinical trials.
This trial tests adding whole-body heat treatment to standard chemotherapy for people with advanced pancreatic cancer that has spread. The heat might make the chemotherapy work better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have pancreatic cancer that has spread to other parts of the body (metastatic).
- You have already had one line of chemotherapy for the metastatic disease.
- You are generally well enough to carry out daily activities (ECOG score 0 or 1).
- Your liver, kidneys, and blood counts are within acceptable ranges.
- You do not have brain metastases, serious heart or lung conditions, or other cancers in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether controlled whole-body heat, given along with standard cancer treatment, can help those therapies work better. It is designed for several specific advanced cancers in situations where care is focused on symptoms and tumor control.
This study is testing a new combination treatment that adds heat therapy to standard chemotherapy and radiation. The goal is to see if this approach can help shrink or control pancreatic tumors that haven't spread to other organs.
This trial tests a treatment that combines heating chemotherapy drugs and delivering them directly into the abdomen (HIPEC) with standard chemotherapy through a vein. It is for people whose pancreatic cancer has spread to the lining of the abdomen but not to other organs, and who have not had prior cancer treatment.
This trial tests a treatment for pancreatic cancer that has spread to the liver (with no more than a few liver tumors). Patients will receive chemotherapy plus surgery and a heat-based procedure (thermal ablation) to destroy the liver tumors. The goal is to see if combining these treatments helps control the cancer better than chemotherapy alone.
This trial tests whether adding hyperthermia (heating the tumor area) to standard immunotherapy drugs can help control advanced gastrointestinal cancers that have spread to the liver. It may be an option if you have already tried other treatments and are looking for a new approach.
This Phase 2 trial tests whether a device that delivers carefully timed “radiofrequency heat” through the body can slow or control metastatic (spread) pancreatic cancer. You may qualify if you have newly diagnosed metastatic pancreatic cancer and can meet safety and blood-test requirements.
Hear when a new Pancreatic Ductal Adenocarcinoma (mPDAC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.